Work

141 Factors associated with significantly corrected sweat chloride in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor—results from the PROMISE and RECOVER studies

Year: 2023

Type: article

Study design: Observational Study

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(23)01074-3

Authors: P. McNally, G. Solomon, D. Nichols, S. Rowe, F. Ratjen, M. Rosenfeld, A. Kelly, L. Kirwan, J. Davies, S. Heltshe

Institutions: Royal College of Surgeons in Ireland, Children's Health Ireland at Crumlin, University College Dublin, University of Limerick, University Hospital Limerick, Harefield Hospital, European Cystic Fibrosis Society, Imperial College London

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Cystic Fibrosis Trust, Berlin Institute of Health

OpenAlex ID: W4387731468

FWCI:

Cites: 1

Cited by:

Related to: 10